Cencora Ventures

Cencora Ventures, formerly known as AB Health Ventures, is the corporate venture arm of Cencora (previously AmerisourceBergen). Launched in 2022, the $150 million fund focuses on investing in early-stage healthcare startups that aim to transform the future of healthcare for both humans and animals. By leveraging Cencora's vast experience and resources, Cencora Ventures offers more than just capital; it actively supports startups with commercialization, distribution, and scalability. The fund is deeply integrated with Cencora’s global pharmaceutical supply chain, allowing it to facilitate connections with healthcare providers, pharmacies, and biotech firms. Cencora Ventures' portfolio includes companies such as SteadyMD, a telehealth infrastructure provider, and Trakcel, which offers solutions for cell and gene therapy orchestration. The fund focuses on areas like digital health, patient management, and decentralized clinical trials, aiming to improve healthcare delivery and outcomes across the globe. With a presence in over 50 countries, Cencora Ventures leverages its parent company’s global network to accelerate the growth of its portfolio companies, offering strategic support such as pilot programs, rapid prototyping, and introductions to a broad customer base. This integration helps emerging companies scale their innovations more efficiently while navigating the complex healthcare ecosystem​.